Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients

Lancet

Volumn 355, Issue 9215, 2000, Pages 1575-1581

  Flather, Marcus D ^a,c,d   Yusuf, Salim ^a,b   Køber, Lars ^e   Pfeffer, Marc ^f   Hall, Alistair ^g   Murray, Gordon ^h   Torp Pedersen, Christian ^e   Ball, Stephen ^g   Pogue, Janice ^a,b   Moyé, Lemuel ⁱ   Braunwald, Eugene ^f  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g Yorkshire Heart Centre   (United Kingdom)

^h UNIVERSITY OF EDINBURGH   (United Kingdom)

ⁱ UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; RAMIPRIL; TRANDOLAPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART DEATH; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART REINFARCTION; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT OUTCOME;

EID: 0010838455     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02212-1     Document Type: Article

References (16)

1. Inhibitor Myocardial Infarction Collaborative Group A.C.E. Indications for ACE inhibitors in the early treatment of acute myocardial infarction. systematic overview of individual data from 100 000 patients in randomized trials Circulation. 97:1998;2202-2212.
2. Pfeffer M.A., Braunwald E., Moyé L.et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. results of the survival and ventricular enlargement trial N Engl J Med. 327:1992;669-677.
3. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:1993;821-828.
4. Kober L., Torp-Pedersen C., Carlsen J.E.et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 333:1995;1670-1676.
5. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
6. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
7. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22:1959;719-748.
8. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction. an overview of the randomized trials Prog Cardiovasc Dis. 27:1985;335-371.
9. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med. 342:2000;145-153.
10. MacMahon S., Peto R., Cutler J.et al. Blood pressure, stroke, and coronary heart disease - part 1, prolonged differences in blood pressure. prospective observational studies corrected for the regression dilution bias Lancet. 335:1990;765-774.
11. Lonn E., Yusuf S., Jha P.et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation. 90:1994;2056-2069.
12. Yusuf S., Lonn E. Anti-ischemic effects of ACE inhibitors. review of current clinical evidence and ongoing clinical trials Eur Heart J. 19(suppl J):1998;36-44.
13. Pitt B., Yusuf S. Studies of left ventricular dysfunction (SOLVD) subgroup results. J Am Coll Cardiol. 19:1992;215.
14. Nguyen K.N., Aursnes I., Kjekshus J. Interaction between enalapril and aspirin on mortality after acute myocardial infarction. subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) Am J Cardiol. 79:1997;115-119.
15. Yusuf S., Wittes J., Probstfield J., Tyroler A. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA. 266:1991;93-98.
16. McKelvie R.S., Yusuf S., Rouleau J.L.et al. Single versus double versus triple therapy to block neurohormonal effects on ventricular remodeling. Circulation. 98:1998;1.